http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107118254-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J73-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J73-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 |
| filingDate | 2016-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107118254-B |
| titleOfInvention | Purposes of the tanshinone II A derivative as MAGL (monoacylglycerol esterase) inhibitor |
| abstract | The present invention relates to field of medicinal chemistry, and in particular to the medical usage of tanshinone IIA derivative (I) and (II).Pharmacological evaluation shows that the compounds of this invention has stronger monoglyceride enzyme inhibition activity and good analgesic activities.The compounds of this invention holds promise for developing the novel analgesic of the clinical use based on monoacylglycerol esterase inhibitor very much. |
| priorityDate | 2016-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 88.